- Abstract:
-
Sufficient evidence points to interleukin 13 (IL-13) as an important pathological factor in UC and raises hopes to a promising new treatment strategy.1–3 However, the outcomes of two recent clinical trials, both published in Gut 2015, suggest otherwise.4 ,5 A commentary published in the same issue described these results as crushing the enthusiasm for anti-IL-13 treatment in UC.6 In this letter, we show evidence that the disease outcome is determined by the type of signalling pathway used by ...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Accepted manuscript
- Files:
-
-
(pdf, 3.8MB)
-
- Publisher copy:
- 10.1136/gutjnl-2016-313208
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
- Publisher:
- BMJ Publishing Group Publisher's website
- Journal:
- Gut Journal website
- Publication date:
- 2017-02-05
- Acceptance date:
- 2017-02-05
- DOI:
- ISSN:
-
1468-3288 and 0017-5749
- Pubs id:
-
pubs:683980
- URN:
-
uri:ed81cd46-8a0d-4691-8917-863139212e79
- UUID:
-
uuid:ed81cd46-8a0d-4691-8917-863139212e79
- Local pid:
- pubs:683980
- Language:
- English
- Keywords:
- Copyright holder:
- BMJ Publishing Group Ltd and British Society of Gastroenterology
- Copyright date:
- 2017
- Notes:
- © 2017 BMJ Publishing Group Ltd and British Society of Gastroenterology. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Journal article
Interleukin 13-mediated colitis in the absence of IL-4Rα signalling.
Actions
Access Document
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Gastroenterology Foundation of South Africa
More from this funder
National Research Foundation
More from this funder
South African Research Chair Initiative
More from this funder
Expand funders...
Bibliographic Details
Item Description
Terms of use
If you are the owner of this record, you can report an update to it here: Report update to this record